Analyst Ratings - Spark Newswire

1 minute read

Cantor Fitzgerald Initiates Coverage On Cipher Mining with Overweight Rating, Announces Price Target of $3

Today, 11:52 PM

Cantor Fitzgerald analyst Josh Siegler initiates coverage on Cipher Mining (NASDAQ:CIFR) with a Overweight rating and announces Price Target of $3.

CIFR

1 minute read

Oppenheimer Downgrades Lightning eMotors to Perform

By Benzinga Newsdesk

Today, 11:52 PM

Oppenheimer analyst Colin Rusch downgrades Lightning eMotors (NYSE:ZEV) from Outperform to Perform.

ZEV

1 minute read

BMO Capital Downgrades Precision BioSciences to Market Perform, Lowers Price Target to $4

By Benzinga Newsdesk

Today, 11:52 PM

BMO Capital analyst Kostas Biliouris downgrades Precision BioSciences (NASDAQ:DTIL) from Outperform to Market Perform and lowers the price target from $7 to $4.

DTIL

1 minute read

JMP Securities Downgrades Seagen to Market Perform

By Benzinga Newsdesk

Today, 11:52 PM

JMP Securities analyst Reni Benjamin downgrades Seagen (NASDAQ:SGEN) from Market Outperform to Market Perform.

SGEN

1 minute read

JP Morgan Downgrades Crestwood Equity Partners to Neutral, Lowers Price Target to $28

By Benzinga Newsdesk

Today, 11:52 PM

JP Morgan analyst Jeremy Tonet downgrades Crestwood Equity Partners (NYSE:CEQP) from Overweight to Neutral and lowers the price target from $31 to $28.

CEQP

1 minute read

‘Do We Need Warren Buffett?’ Cramer Is Puzzled By Plunge In Banking Stocks

By Shanthi Rexaline

Today, 11:52 PM

CNBC “Mad Money” host Jim Cramer mulled over the potential outcome of the abysmal sell-off in the regional banks in the wake of the collapse of the Silicon Valley Bank owned by SVB Financial Group (NASDAQ:

FRC

1 minute read

Raymond James Downgrades Qualtrics International to Market Perform

By Benzinga Newsdesk

Today, 11:52 PM

Raymond James analyst Brian Peterson downgrades Qualtrics International (NASDAQ:XM) from Outperform to Market Perform.

1 minute read

Jefferies Downgrades Provention Bio to Hold, Announces $25 Price Target

By Benzinga Newsdesk

Today, 11:52 PM

Jefferies analyst Chris Howerton downgrades Provention Bio (NASDAQ:PRVB) from Buy to Hold and announces $25 price target.

PRVB

1 minute read

Keefe, Bruyette & Woods Upgrades Unum Gr to Outperform, Raises Price Target to $52

By Benzinga Newsdesk

Today, 11:52 PM

Keefe, Bruyette & Woods analyst Ryan Krueger upgrades Unum Gr (NYSE:UNM) from Market Perform to Outperform and raises the price target from $49 to $52.

UNM

1 minute read